Prognostic factors and life expectancy in canine leishmaniosis

Detalhes bibliográficos
Autor(a) principal: Pereira, Maria Aires
Data de Publicação: 2020
Outros Autores: Santos, Rute, Oliveira, Ricardo, Costa, Lina, Prata, Ana, Gonçalves, Vânia, Roquette, Madalena, Vala, Helena, Santos-Gomes, Gabriela
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/116646
Resumo: Canine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3-4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL.
id RCAP_cf91f14d00d1cded06252d9c595059de
oai_identifier_str oai:run.unl.pt:10362/116646
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Prognostic factors and life expectancy in canine leishmaniosisCanine leishmaniosisIris stagingPrognostic factorsSurvival timeTherapy selection and managementveterinary(all)Infectious DiseasesSDG 3 - Good Health and Well-beingCanine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3-4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL.Instituto de Higiene e Medicina Tropical (IHMT)Vector borne diseases and pathogens (VBD)Global Health and Tropical Medicine (GHTM)RUNPereira, Maria AiresSantos, RuteOliveira, RicardoCosta, LinaPrata, AnaGonçalves, VâniaRoquette, MadalenaVala, HelenaSantos-Gomes, Gabriela2021-05-01T22:54:21Z2020-09-042020-09-04T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article16application/pdfhttp://hdl.handle.net/10362/116646eng2306-7381PURE: 27533718https://doi.org/10.3390/vetsci7030128info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:59:20Zoai:run.unl.pt:10362/116646Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:43:11.823946Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Prognostic factors and life expectancy in canine leishmaniosis
title Prognostic factors and life expectancy in canine leishmaniosis
spellingShingle Prognostic factors and life expectancy in canine leishmaniosis
Pereira, Maria Aires
Canine leishmaniosis
Iris staging
Prognostic factors
Survival time
Therapy selection and management
veterinary(all)
Infectious Diseases
SDG 3 - Good Health and Well-being
title_short Prognostic factors and life expectancy in canine leishmaniosis
title_full Prognostic factors and life expectancy in canine leishmaniosis
title_fullStr Prognostic factors and life expectancy in canine leishmaniosis
title_full_unstemmed Prognostic factors and life expectancy in canine leishmaniosis
title_sort Prognostic factors and life expectancy in canine leishmaniosis
author Pereira, Maria Aires
author_facet Pereira, Maria Aires
Santos, Rute
Oliveira, Ricardo
Costa, Lina
Prata, Ana
Gonçalves, Vânia
Roquette, Madalena
Vala, Helena
Santos-Gomes, Gabriela
author_role author
author2 Santos, Rute
Oliveira, Ricardo
Costa, Lina
Prata, Ana
Gonçalves, Vânia
Roquette, Madalena
Vala, Helena
Santos-Gomes, Gabriela
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Instituto de Higiene e Medicina Tropical (IHMT)
Vector borne diseases and pathogens (VBD)
Global Health and Tropical Medicine (GHTM)
RUN
dc.contributor.author.fl_str_mv Pereira, Maria Aires
Santos, Rute
Oliveira, Ricardo
Costa, Lina
Prata, Ana
Gonçalves, Vânia
Roquette, Madalena
Vala, Helena
Santos-Gomes, Gabriela
dc.subject.por.fl_str_mv Canine leishmaniosis
Iris staging
Prognostic factors
Survival time
Therapy selection and management
veterinary(all)
Infectious Diseases
SDG 3 - Good Health and Well-being
topic Canine leishmaniosis
Iris staging
Prognostic factors
Survival time
Therapy selection and management
veterinary(all)
Infectious Diseases
SDG 3 - Good Health and Well-being
description Canine leishmaniosis (CanL) is a chronic and potentially fatal disease. The prognosis of CanL depends on the severity of the clinical signs and clinicopathological abnormalities presented by the dog at the time of diagnosis. This study aims to estimate the survival time of dogs with CanL, determining the prognostic value of different clinical and clinicopathological parameters. Medical records of 99 dogs diagnosed with CanL in five veterinary centers of the Alentejo region (Portugal) were examined retrospectively. The majority of dogs presented hyperproteinemia, moderate normocytic normochromic anemia, normal blood urea and creatinine levels and were classified as stage 1 according to the International Interest Society (IRIS) guidelines at the time of diagnosis. The severity of anemia, presence of concomitant infectious diseases at the time of diagnosis and the anti-Leishmania therapy were correlated with the survival time. The influence of renal dysfunction was evaluated by Receiver Operating Characteristic (ROC) curve and survival analysis. Survival analysis demonstrated that patients classified as IRIS 1 at the time of diagnosis survived more than four years, in contrast with dogs classified as IRIS 2 that survived around two and half years and dogs classified as IRIS 3-4 that survived around one month. IRIS stage deteriorated during the course of CanL in one third of the dogs and was the principal cause of death or euthanasia in a high proportion of animals. In some cases, dogs did not receive anti-Leishmania treatment or abandoned the veterinary follow-ups, which may have considerable repercussions for animal wellbeing and public health. This study reinforces the value of blood urea and creatinine levels as prognostic factors in CanL.
publishDate 2020
dc.date.none.fl_str_mv 2020-09-04
2020-09-04T00:00:00Z
2021-05-01T22:54:21Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/116646
url http://hdl.handle.net/10362/116646
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2306-7381
PURE: 27533718
https://doi.org/10.3390/vetsci7030128
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 16
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138041986547712